DealsKeensight portfolio firm Symeres brings in Exemplify BioPharmaExemplify BioPharma is Symeres’ second acquisition in the US this year.ByNina Lindholm25 October 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsNorth AmericaUSHealthcareBriefs